Alternative transcription initiation leads to expression of a novel ALK isoform in cancer Journal Article
| Authors: | Wiesner, T.; Lee, W.; Obenauf, A. C.; Ran, L.; Murali, R.; Zhang, Q.; Wong, E. W. P.; Hu, W.; Scott, S. N.; Shah, R. H.; Landa, I.; Button, J.; Lailler, N.; Sboner, A.; Gao, D.; Murphy, D. A.; Cao, Z.; Shukla, S.; Hollmann, T. J.; Wang, L.; Borsu, L.; Merghoub, T.; Schwartz, G. K.; Postow, M. A.; Ariyan, C. E.; Fagin, J. A.; Zheng, D.; Ladanyi, M.; Busam, K. J.; Berger, M. F.; Chen, Y.; Chi, P. |
| Article Title: | Alternative transcription initiation leads to expression of a novel ALK isoform in cancer |
| Abstract: | Activation of oncogenes by mechanisms other than genetic aberrations such as mutations, translocations, or amplifications is largely undefined. Here we report a novel isoform of the anaplastic lymphoma kinase (ALK) that is expressed in ∼11% of melanomas and sporadically in other human cancer types, but not in normal tissues. The novel ALK transcript initiates from a de novo alternative transcription initiation (ATI) site in ALK intron 19, and was termed ALKATI. In ALKATI -expressing tumours, the ATI site is enriched for H3K4me3 and RNA polymerase II, chromatin marks characteristic of active transcription initiation sites. ALKATI is expressed from both ALK alleles, and no recurrent genetic aberrations are found at the ALK locus, indicating that the transcriptional activation is independent of genetic aberrations at the ALK locus. The ALKATI transcript encodes three proteins with molecular weights of 61.1, 60.8 and 58.7 kilodaltons, consisting primarily of the intracellular tyrosine kinase domain. ALKATI stimulates multiple oncogenic signalling pathways, drives growth-factor-independent cell proliferation in vitro, and promotes tumorigenesis in vivo in mouse models. ALK inhibitors can suppress the kinase activity of ALKATI, suggesting that patients with ALK ATI -expressing tumours may benefit from ALK inhibitors. Our findings suggest a novel mechanism of oncogene activation in cancer through de novo alternative transcription initiation. © 2015 Macmillan Publishers Limited. All rights reserved. |
| Journal Title: | Nature |
| Volume: | 526 |
| Issue: | 7573 |
| ISSN: | 0028-0836 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2015-10-15 |
| Start Page: | 453 |
| End Page: | 457 |
| Language: | English |
| DOI: | 10.1038/nature15258 |
| PROVIDER: | scopus |
| PUBMED: | 26444240 |
| PMCID: | PMC4807020 |
| DOI/URL: | |
| Notes: | Export Date: 2 November 2015 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work